Eledon Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.4 | – | – | 14.2 | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,857.7 | 972.8 | 440.8 | 325.1 | 382.7 | 524.1 | 465,747.5 | 285,318.1 | 332,871.1 | – | – | – | – | – | – | 196.3 | 247.7 | 259.7 | 277.8 | 542.5 | 522.4 | – | – | – | |
| 0.0 | 0.8 | 0.1 | 18.8 | 31.5 | – | 28.7 | 55.1 | 43.5 | 18.7 | 68.4 | 13.2 | 10.8 | 14.3 | 10.3 | 15.0 | 15.9 | 1.2 | 0.9 | 0.7 | 0.5 | 0.4 | 0.4 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.5 | 0.5 | 0.8 | – | 1.8 | 2.1 | 2.3 | 2.0 | 5.7 | 1.4 | 3.5 | 6.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,905.5 | 497.6 | 139.5 | 44.7 | -8.4 | -179.1 | -170,494.1 | -299,456.9 | -213,053.9 | – | – | – | – | – | – | 150.3 | 235.9 | 238.2 | 269.1 | 528.4 | 513.8 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.8 | – | – | 13.3 | – | – | – | – | |
| -3,490.6% | -164.7% | -957.2% | -5.8% | -3.0% | -52.5% | -2.0% | -1.0% | -1.4% | -4.4% | -2.0% | -7.2% | -10.5% | -10.2% | -9.9% | -7.2% | -2.3% | -6.5% | -11.5% | -19.3% | -31.7% | -45.9% | -57.1% | -89.6% | -70.5% | -89.7% | -88.1% | -95.8% | -95.0% | -90.7% | -60.9% | -34.5% | -27.0% | -19.3% | -20.8% | -31.0% | -33.5% | -55.1% | -19.8% | -16.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -153.3% | -76.3% | -50.8% | -50.3% | -74.6% | -162.3% | -201,666.7% | -243,333.3% | -284,166.7% | – | – | – | – | – | – | -67.9% | -65.2% | -38.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -13,570.0% | -7,693.8% | -6,692.2% | -8,186.7% | -14,095.8% | -30,691.8% | -31,434,166.7% | -32,527,500.0% | -32,604,166.7% | – | – | – | – | – | – | -8,376.3% | -10,039.1% | -7,476.4% | -8,228.0% | -22,891.4% | -22,516.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -17,542.5% | -9,504.6% | -6,425.8% | -7,758.6% | -13,168.3% | -28,726.3% | -29,892,500.0% | -31,445,000.0% | -31,990,000.0% | – | – | – | – | – | – | -13,345.4% | 2,168.4% | -2,420.3% | -2,017.8% | 3,813.3% | -20,777.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6,501.7% | -6,338.3% | -5,050.3% | -6,279.4% | -12,140.8% | -24,070.1% | -26,585,833.3% | -25,561,666.7% | -23,460,000.0% | – | – | – | – | – | – | -6,767.3% | -6,681.3% | -5,007.5% | -5,782.8% | -16,804.4% | -17,509.6% | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -84.2% | -67.8% | -34.9% | -58.9% | -71.5% | – | -59.9% | -51.5% | -63.3% | -97.1% | -162.6% | -106.3% | -123.0% | -169.2% | -164.4% | -190.3% | -97.9% | -12.0% | -12.6% | -15.6% | -18.5% | -21.0% | -22.9% | -25.3% | -27.2% | -104.5% | -118.8% | -145.5% | -158.6% | -115.2% | -127.8% | – | 16.0% | -19.3% | -16.6% | 13.8% | -225.6% | -56.3% | -77.8% | -136.8% | |
| -69.4% | -61.2% | -31.5% | -51.4% | -64.0% | -62.8% | -56.1% | -48.2% | -58.2% | -82.6% | -120.0% | -93.6% | -108.0% | -146.5% | -140.7% | -169.5% | -10.9% | -11.6% | -12.1% | -15.2% | -17.8% | -20.2% | -22.2% | -24.4% | -25.7% | -94.8% | -108.0% | -136.1% | -150.7% | -76.3% | -118.3% | -62.0% | 10.6% | -12.9% | -11.8% | 10.1% | -61.4% | -27.0% | -53.3% | -78.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -19 | -20 | – | – | – | – | – | – | – | – | -8.9 | -14 | -11 | -8.6 | -12 | -8.6 | -114 | -114 | -108 | -101 | -94 | -84 | -76 | -70 | -66 | -56 | -46 | -41 | -3.3 | -4.2 | -5.4 | -26 | -6.6 | -20 | -8.2 | -5.4 | -3.3 | -22 | -5.8 | -6.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.6 | – | – | -0.4 | – | – | – | – | |
| 82.4% | 90.2% | 90.4% | 87.3% | 89.6% | – | 93.8% | 93.7% | 92.0% | 85.1% | 73.8% | 88.0% | 87.8% | 86.6% | 85.6% | 89.1% | 11.2% | 96.7% | 95.9% | 96.9% | 96.4% | 96.2% | 96.9% | 96.6% | 94.3% | 90.7% | 90.9% | 93.6% | 95.1% | 66.3% | 92.6% | -7.1% | 66.4% | 66.6% | 71.0% | 73.2% | 27.2% | 48.0% | 68.5% | 57.1% | |
| 0.0 | 0.1 | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -5,639.66 | -130.25 | -354.58 | -3.32 | -2.12 | -34.00 | -1.88 | -1.18 | -1.23 | -1.49 | -1.71 | -1.45 | -1.27 | -1.23 | -1.12 | -1.05 | -1.05 | -1.50 | -1.56 | -1.89 | -2.13 | -2.41 | -2.50 | -2.65 | -2.69 | -6.39 | -6.22 | -6.06 | -4.83 | -3.97 | -3.19 | -1.77 | 0.22 | -0.38 | -0.25 | 0.19 | -1.03 | -0.60 | -0.70 | -0.87 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 6,696.99 | 192.21 | 1,016.75 | 5.64 | 2.97 | – | 3.14 | 2.29 | 1.95 | 1.54 | 1.05 | 1.36 | 1.03 | 0.73 | 0.68 | 0.55 | 1.07 | 12.57 | 12.40 | 12.05 | 11.52 | 11.46 | 10.91 | 10.47 | 9.89 | 6.11 | 5.24 | 4.16 | 3.05 | 3.45 | 2.49 | -0.20 | 1.37 | 1.98 | 1.49 | 1.37 | 0.46 | 1.07 | 0.89 | 0.63 | |
| -8,482.07 | -261.49 | -1,302.49 | -6.11 | -2.83 | -38.73 | -1.81 | -1.24 | -1.18 | -1.26 | -1.45 | -1.30 | -1.17 | -1.07 | -0.70 | -0.60 | -0.39 | -1.00 | -1.23 | -1.53 | -1.97 | -2.02 | -2.23 | -2.15 | -1.97 | -2.06 | -2.11 | -1.34 | -1.33 | -1.63 | -1.28 | -0.90 | -0.67 | -0.79 | -0.71 | -0.84 | -0.87 | -0.83 | -0.61 | -0.65 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.